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Intestinal Absorption and Metabolism of
Xenobiotics
by Rajendra S. Chhabra*
There are five possible processes of intestinal absorption of xenobiotics. These are active transport,
passivediffusions, pinocytosis,filtrationthrough"pores," andlymphaticabsorption. Thepassivediffusion
ismajorprocessfortransportofforeignchemicalsacrosstheintestine. Thoughthelymphatic absorptionof
drugsisnotofanymajortherapeuticsignificance, theuptakeoftoxicchemicalssuchas3-MC, benzpyrene,
andDDT through lymphatics may enhance theirtoxicity, sincethey are distributed tootherorgansystems
in the body without being metabolized by liver. A number of factors such as diet, motility of intestine,
interference with gastrointestinal flora, changes in the rate of gastric emptying, age of the animal, and
dibsolution rate of xenobiotic can alter the rate of absorption of chemicals.
Liver is the major site of metabolism of xenobiotlcs, but the contribution of intestinal metabolism of
xenobiotic can influence the overall bioavailability of chemicals. The xenobiotic metabolizing enzymes
oated inendoplasmic reticulum ofintestine possessbiochemicalcharacteristics similar tothat ofliver. In
general, the rate of metabolism of xenobiotics by intestinal microsomal preparation is lower than that
observedwith similarhepatic microsomal preparations. Theinvitro intestinal metabolismofxenobiotics is
affected by several factors including age, sex, diurnal variations, species, and nutritional status of the
aninal. The intestinal xenobioticmetabolizing enzymes are stimulated bythepretreatmentofanimalswith
foreign chemicals, but this depends on the route of administration ofchemicals, drug substrate and the
aninal species used. Rabbit intestinal drug metabolizing enzymes seem to be resistant to induction by
foreign chemicals.
Introduction
The chemicals foreign to the biologic system are
referred to as xenobiotics. Xenobiotics can be clas-
sified in four broad categories (1): (1) natural chemi-
cals in excess of the normal dietary level such as
nitrates; nitrites, the metabolites ofnitrates can react
in vitro and in vivo with secondary amines and form
carcinogenic products nitrosamines; (2) the af-
latoxins and cycasins are examples ofnatural fungal
orplanttoxins; (3)airand waterpollutantsconsisting
ofcomplex inorganic andorganicchemical mixtures;
and (4) the largest category: drugs, agricultural
chemicals such as pesticides and fertilizers, food
additives, heavy metals, plasticizers, and industrial
and household chemicals including solvents. The
number of chemicals in everyday use ranges from
50,000 to 63,000 (2). There are over 500 chemicals
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added intentionally to food in addition to uninten-
tional contamination of food by a variety of other
chemicals (3). The human population is exposed to
xenobiotics through inhalation, ingestion, or dermal
absorption. The major route ofexposure is the oral
route, through which intestinal ingestion of
therapeutic agents and unintentional exposure ofen-
vironmental pollutants present in food and water as
well as the swallowing of part of inhaled pollutants
occurs. After absorption, the xenobiotics may be
distributed in the blood stream as well as in intersti-
tial cellular and transcellular fluids. The physio-
chemical characteristics ofxenobiotics, cardiac out-
put, and regional blood circulation are the major
determining factors which influence the rate, extent
and pattern of initial distribution. The lipid-soluble
chemicals are readily distributed in all fluid com-
partments and in highly perfused tissues but move
less rapidly into muscles and more slowly to fats.
The xenobiotics, after absorption can accumulate in
tissues which may serve as reservoirandprolongthe
toxicity of chemicals or the therapeutic effect of
December 1979 61chemicals when taken as medication. A large num-
ber of xenobiotics are lipid-soluble, weak organic
acids or bases that are not readily eliminated from
thebody. They must be transformed into more polar
metabolites before they are excreted from the body.
Afterbiotransformation, usually the end products of
xenobiotics are less lipid-soluble, more ionized at
physiological pH, less bound to plasma and tissue
protein, and less stored in fat.
This paper presents an overview of xenobiotic
absorption and metabolism by intestine; for in-depth
information on this subject, reader is referred to
reviews on absorption (4-9) and intestinal metab-
olism of chemicals (10-12).
Intestinal Absorption of
Xenobiotics
Xenobiotics must cross the intestinal epithelium,
basement membrane and capillary endothelium be-
fore they reach the blood stream. Mammals do not
absorb the xenobiotics through any special transport
process but sharethe same processeswhich are used
for absorption of nutrients. There are five possible
processes of xenobiotic transport across intestines.
These are: active transport, passive diffusion,
pinocytosis, filtration through "pores," and lym-
phatic absorption.
Active Transport
Active transport processes require cellular energy
for transfer of substrates across intestine against
higher concentration or electrochemical gradients.
This system exists mainly fortransferofnatural sub-
stances, e.g., amino acids, sugars, or bile acids.
Mostoftheforeign chemicals utilize passive diffu-
sion process oftransport, but there are examples of
active transport for xenobiotics which are structur-
ally similar to natural substrates. The antitumor
agents 5-fluorouracil and 5-bromouracil are actively
transported across the rat intestinal epithelium by
the process through which natural pyrimidines,
uracil and thymine are absorbed (6). It seems that
lead, an inorganic environmental contaminant, may
utilize the active transport process ofcalcium for its
transport (9).
Pinocytosis
In pinocytosis the cell membrane forms invagina-
tions which finally close to form vesicles containing
fluid from outside the cell. Inside the cell, the con-
tents ofthese vesicles are delivered tocytoplasm. In
suckling animals this process oftransport is used for
macromolecules, e.g., antigenic peptides and im-
munoactive protein.
Filtration through "Pores"
Both lipophilic and hydrophilic compounds may
pass through "pores" in the cell membrane.
Xenobiotics with molecular weight around 100 may
be absorbed through this process.
Absorption via the Lymphatics
It is well known that dietary short-chained fatty
acids are predominantly absorbed via the lymphatic
system in minute droplets known as chylomicrons.
These enter the thoracic duct and empty into the
systemic venous blood, completely bypassing the
liver. A very few systematic studies on xenobiotic
absorption through intestinal lymphatics are known.
DeMarco and Levine (13) have studied the absorp-
tion of some drugs through this process and have
shownthatcompounds suchasp-aminosalicylic acid
and tetracycline are absorbed to some extent
through the lymphatic system, but the proportion of
absorption is too low to be ofanytherapeutic signifi-
cance. However, the absorption of environmental
toxic chemicals through intestinal lymphatics is im-
portant since these chemicals can be distributed
throughout the body without being transformed by
theliver. Some ofthe environmental toxicchemicals
such as DDT, benzpyrene, and 3-methyl-cholan-
threne(3-MC) are partly absorbed through lym-
phatics. Sieber (14, 15) studied the absorption of
14C-labeled compounds structurally related to p, p'-
DDT in thoracic cannulated rats and identified the
parent DDT compounds and their metabolites in the
lymph collected during the experiment. The DDT
compounds varied in their lipid solubility and extent
oftheirlymphatic absorption, butastrictcorrelation
between lipid solubility and lymphatic absorption
was not established, possibly due to other factors
such as differences in rate and routes ofexcretion of
each compound. The carcinogens, benzpyrene,
3-MC, and cis-dimethylaminostilbene are also ab-
sorbed through intestinal lymphatics (16, 17).
The absorption of xenobiotics through intestinal
lymphatics is influenced by the lymphflow rate. For
example, the absorptionofp-aminosalicylic acidand
tetracycline was doubled whenintestinal lymphflow
was increased by the administration of tripalmitine
(18).
Passive Diffusion
Passive diffusion is the major process for absorp-
tionofxenobiotics. This process is not saturable and
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tration gradient and to the lipid-water partition coef-
ficient of xenobiotics. The higher these are, the fas-
terthe rateofdiffusion, and whentheconcentrations
are the same on both sides ofthe membrane, move-
mentofxenobiotics across the membrane stops. Ab-
sorption of structurally related chemicals occurs in-
dependently; coabsorption does not alterabsorption
rate ofeither chemical. The extent oflipid solubility
and ionization of xenobiotics influences the rate of
absorption of chemicals (6). Many weak acids and
bases are readily absorbed while stronger, more
highly ionized acids and bases are less readily trans-
ported. Completely ionized compounds are very
slowly absorbed. The role of ionization on absorp-
tion ofchemicals is further supported by the change
in the rate ofabsorption that resulted from a change
in pH of the rat intestinal contents. For instance,
raisingthe pH increased the absorptionofbases such
as quinine and aminopyrine and decreased the ab-
sorption of acids, such as benzoate and salicylates
(6).
Factors Affecting Intestinal Absorption of
Xenobiotics
A number of factors can influence the intestinal
absorption of xenobiotics. For example, serum
levels of phenobarbital, when administered orally,
were higher in fasted animals than in the animals
which were fed ad libitum (19). Recently Engstrom
and Nordburg looked at the effect of milk diet on
gastrointestinal absorption of cadmium in adult
mice. A markedly higherbody retention of109CdC12
was observed in animals given a milk diet compared
to other groups on laboratory chow (20).
Bile may play some role in absorption ofxenobio-
tics. In a recent study (21) on absorption ofradioac-
tive lead, it was found that absorption of 203Pb ad-
ministered into the duodenum was decreased in rats
with cannulated bile ducts. Mice showed no differ-
ence between absorption of biliary excreted 203Pb
and of 203Pb administered into duodenum in rats
withoutcannulation ofthe bile duct. Presence ofbile
seemed to enhance the intestinal transport of lead.
The absorption and retention of xenobiotics may
be affected by the age of the animal. Cadmium in
newborn rats isabsorbed greaterthaninadults and is
retained in the intestine for a longer time (22).
A number ofother factors influence the intestinal
absorption ofxenobiotics which include the changes
in motility of intestinal tract; interference with gas-
trointestinal contents ofmicroorganisms; changes in
the rate ofgastric emptying in either direction; dis-
solution rate of xenobiotics. Further details on this
topic are available in the literature (8, 18, 23).
Metabolism of Xenobiotics
The chemical reactions involved in metabolism of
xenobiotics are classified as phase I and phase II
reactions. The phase I or nonsynthetic reactions are
oxidation, reduction, or hydrolysis. The phase I
reactions of xenobiotic metabolism may result in
activation, change in activity or inactivation of par-
entchemical. The phase II or synthetic reactions are
concerned with formation of complex with the par-
ent chemical or its metabolite with an endogenous
substrate which usually results in rendering ofparent
compound to an inactive form. Liver is the major
organ where these phase I and phase II reactions or
biotransformation or toxication-detoxication reac-
tions of xenobiotics take place. The hepatic endo-
plasmic reticulum contains a group of nonspecific
enzymes which catalyze the metabolic reactions of a
variety of xenobiotics as well as that ofnatural sub-
strates such as fatty acids and steroids. These en-
zyme systems require NADPH, molecular oxygen,
and an electron transport system consisting of
NADPHcytochrome c reductase, lipid, and acarbon
monoxide binding pigment generally known as
cytochrome P-450. The reaction products of
xenobiotics by these enzyme systems are usually
less lipid soluble and are excreted as such or after
conjugation. The hepatic metabolism of foreign
chemicals has been extensively studied and re-
viewed (24, 25).
For the last several years our laboratory has been
studying the comparative aspects of biochemical
properties of intestinal and hepatic xenobiotic
metabolizing enzymes (12). All these studies were
conducted in vitro by using microsomal fractions
prepared from intestinal and hepatic homogenates.
The in vitro metabolism of model drug substrates
was studied by standard analytical methods. The
details of methodology for preparation of micro-
somal fractions and estimation ofdrug metabolizing
enzymss are well documented in the literature (26).
Following are the major characteristics ofintestinal
xenobiotic metabolizing enzymes studied in our lab-
oratory.
Localization, Distribution, and Some
Biochemical Properties of Intestinal
Xenobiotic Metabolizing Enzymes
The intestinal xenobiotic metabolizing enzymes
are localized in endoplasmic reticulum of epithelial
cells. The distribution studies of these enzymes
along the entire length of small intestine show that
the activity of these enzymes is highest in proximal
part of intestine and progressively declines towards
the caudal end. Figure 1 shows the distribution of
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FIGURE 1. Distribution of microsomal drug metabolizing enzymes and cytochrome P-450 content along the proximal 60 in. of rabbit
small intestine.
ethylmorphine-N-demethylase, aniline hydrox-
ylase, andbenzpyrene hydroxylase activities (AHH)
and cytochrome P-450 content along the proximal 60
in. ofrabbit intestine. The activities ofall xenobiotic
metabolizing enzymes were highest in the first 30 in.
of the intestines. However, the cytochrome P-450
contents were similar in entire length of intestine
used in this study. The rat and mice xenobiotic
metabolizing enzymes also have similar patterns of
distribution in intestines (27, 28) as seen in rabbits. A
recent study on distribution of xenobiotic metabo-
lizing enzymes among mucosal cell population
showed that mature tip cells contained 6-10 times
morecytochrome P-450 and xenobiotic metabolizing
enzyme activity per mg of microsomal protein than
the crypt epithelial cells (29, 30). A recent study
shows (31) that crypt and tip cells differ in their
response to inductive actions of2, 3, 7, 8-tetrachlo-
rodibenzo-p-dioxin (TCDD).
The comparison of rabbit intestinal and hepatic
metabolism of a number of drug substrates showed
that the activities were generally lower in intestine.
The activities of intestinal drug metabolizing en-
zymes were 15-50%o0 of those observed in hepatic
microsomes. The study on biochemical properties of
both hepatic and intestinal enzyme systems showed
that both systems require NADPH and 02 for
maximum activity and are inhibited by cytochrome
c, SKF-525A, and CO. The in vitro addition ofdrug
substrates to microsomal fractions of both tissues
produced typical type 1 and type II binding spectra
(32), again suggesting similarities in the enzyme
systems from liver and intestine.
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Perinatal Development of Intestinal
Xenobiotic Metabolizing Enzymes
The postnatal development of aminopyrine N-
demethylase, benzpyrene hydroxylase, biphenyl
4-hydroxylase, 7-ethoxycoumarin 0-deethylase,
NADPH-cyctochrome c reductase activities, and
cytochrome P-450 content were compared in micro-
somesfromtheliverand smallintestinesoftherabbit
(33). The common developmental pattern observed
was characterized by enzyme activities which were
low or undetectable in the first week after birth and
increased slowly during the first 25 days oflife. Sub-
sequently, the enzyme activities underwent a rapid 2
to5-foldincrease inmagnitude. By30-40daysofage,
values reached or exceeded adult level. At 50 days
there was a transient fall in enzyme activities below
adult level, but activities returned to adult levels by
75 days postpartum. The same pattern of hepatic
enzyme development was noticed except that
maximumactivities were usuallyobservedlaterthan
in the small intestine. Also, no subsequent decline
below adult values was observed for any of the
hepatic enzyme activities studied during later de-
velopment. The typical pattern of development of
enzymes is represented by the postnatal maturation
ofAHH shown in Figure 2.
Recently Lucier et al. (34) studied the develop-
mental patterns of UDP-glucuronyl transferase
(UDPGT) activities inguineapigand rabbit intestine
during perinatal period. The guinea pig intestinal
UDPGTactivities were notdetectableuntilbirth and
developed to adult levels by 3 weeks after birth.
However, the rabbit intestinal UDPGT activities
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Aweredetectable 10daysbeforebirth, declined during
thefirst weekafterbirth, and attained adultlevels by
4 weeks of age.
Rhythmic Variations in Intestinal Xenobiotic
Metabolizing Enzymes
Changes in the susceptibility ofbiologic system to
therapeutic ortoxic effect ofchemicals maybe influ-
enced by the time ofday at which they are exposed.
Theroleofcircadian rhythms inratesofextrahepatic
drug metabolizing enzymes was recently reported
from our laboratory (35). The circadian variations in
various microsomal drug metabolizing enzymes
from rabbit intestine are shown in Table 1. All en-
zyme activities showed a peak in activity around
0600 hr with a trough around 1200-1500 hr. For
biphenyl hydroxylase, aryl hydrocarbon hydrox-
ylase and NADPH cytochrome c reductase activ-
ities, the values ofthese enzymes were significantly
different. The microsomal cytochromic P-450 con-
tent appeared less rhythmic than the enzymic ac-
tivities measured.
Nutrition as a Modifier of Intestinal
Xenobiotic Metabolizing Enzymes
The importance ofdietary components as poten-
tialeffectors ofintestinaldrugmetabolizingenzymes
has been extensively studied by Wattenberg and his
colleagues (27, 36, 37). Most of their studies were
concentrated on the AHH enzyme system in rat. In
their studies on the effect of various diets on AHH
activities in rat intestine and lung, it was shown that
rats on semipurified diet lost all AHH activities in
ADULT
DAYS POST PARTUM
FIGuRE 2. Development with age of the activity of benzpyrene
hydroxylase inhepaticand small intestinal rabbitmicrosomes.
Figure from Tredgeret al. (33) reproduced with permission of
the American Society for Pharmacology and Experimental
Therapeutics.
these tissues. From these experiments, it was sug-
gested that intestinal enzyme activities observed in
ratsonnormal laboratory chow areduetotheexoge-
nous factors present in the diet which induce the
enzyme activities present at very low levels. This
hypothesis was confirmed by their findings that
addition ofvarious vegetables to a semipurified diet
caused increases in intestinal AHH activity in rat
(38). Table 2 shows our current studies where the
rabbit was used as an experimental animal and the
effect of semipurified diet on some of the drug
metabolizing enzymes was compared with the en-
zymes in animals on regular laboratory rabbit chow.
Unlike the rat (37), the intestinal enzymic activities
Table 1. Circadian variations in rabbit intestinal microsomal enzyme activities.a
Time (hr)
Enzyme activity 0000 0300 0600 0900 1200 1500 1800 2100
Aryl hydrocarbon
hydroxylase, pmole 3-
hydroxybenzpyrene pro-
duced/mg microsomal pro-
tein/min 54 ± 8 58 ± 7 67 ± 6 61 ± 6 51 ± 2 61 ± 10 58 ± 11 53 ± 4
Benzphetamine N-demethylase,
nmole formaldehyde pro-
duced/mg microsomal pro-
tein/min 0.51 ± 0.08 0.57 ± 0.06 0.64 ± 0.08 0.54 ± 0.04 0.48 ± 0.06 0.47 ± 0.10 0.59 ± 0.11 0.60 ± 0.04
NADPH-Cytochrome c reduc-
tase, nmole cytochrome c re-
duced/mg microsomal pro-
tein/min 86 ± 13 97 ± 7 104 ± 12 84 ± 8 81 ± 7 89 ± 16 89 ± 10 94 ± 11
Cytochrome P-450,
nmole/mgmicrosomalprotein 0.43 ± 0.03 0.44 ± 0.04 0.50 ± 0.05 0.45 ± 0.02 0.51 ± 0.02 0.49 ± 0.03 0.49 ± 0.06 0.48 ± 0.01
aDatafromTredgerandChhabra(35). Animals were killedatthe times shownand microsomal fractions were immediately preparedand stored.
Enzyme activities were determined within I week of sacrifice. Each value is the mean ± S.E.M. of four separate determinations.
December 1979 65Table 2. Effect of purified diet on intestinal drug-metabolizing enzymes in rabbit.
Enzyme activity, % ofcontrolsa
Ethylmorphine Aniline Arylhydrocarbon 7-Ethoxycoumarin
Treatment demethylase hydroxylase hydroxylase (AHH) deethylase
Purified diet vs. pair-fed controls 82 95 77 110
Purified diet vs. ad lib controls 99 104 87 125
aControls were fed a natural ingredient rabbit diet, either pair-fed to the purified diet group or fed ad lib.
Table 3. Species differences in intestinal microsomal drug-metabolizing enzymes and cytochrome P-450 content.a
Enzyme activity in intestine as percent of that in liver
Ethyl morphine Biphenyl Aniline Benzpyrene Cytochrome c Cytochrome
Species N-demethylase hydroxylase hydroxylase hydroxylase reductase P-450
Rabbit 18.6 14.1 20.4 30.0 75.7 34.6
Guinea pig 23.3 16.4 19.8 37.4 78.7 12.4
Rat NDa 9.3 ND 4.6 42.0 ND
Mice ND 9.0 ND 6.0 79.6 4.0
Hamster ND 6.8 ND 5.7 60.7 13.0
aData compiled from Chhabra et al. (39).
bNot detected.
Table 4. Effect of phenobarbital on intestinal microsomal drug-metabolizing enzymes.
Enzyme activity, % of control
Route of Ethylmorphine Aniline Arylhydrocarbon 7-Ethoxycoumarin
Species administration demethylase hydroxylase hydroxylase (AHH) deethylase
Mouse Oral NDa NDb b
IP ND ND 478b 406b
Rat Oral ND ND 178 109
IP ND ND 27 251b
Guinea pig Oral 137b 120 93 248b
IP 113 66 85 163
Rabbit Oral 93 86 62 139
IP 112 82 90 69
aNot detected.
bSignificantly different from control, p < 0.05.
inrabbitfed semipurified diets were not altered. The
reason for this apparent species difference are not
immediately obvious but may be ofconsiderable im-
portance should a regulatory role be envisioned for
diet in the control of enzyme activities in the small
intestine of all mammals including man.
Dfferences in Intestinal Xenobiotic
Metabolizing Enzymes and Their Induction
by Foreign Chemicals in Various Species
Table 3 shows the activities of various drug
metabolizing enzymes as percent ofliver activity in
various animal species. In the intestines from mice,
rat, guinea pigs, and hamsters, some ofthe enzymic
activities wereeitherabsent orrequire very sensitive
methods of detection. The rabbit emerged as the
species with highest activities of drug metabolizing
enzymes. The interspecies difference noticed in in-
testinal drug metabolizing enzymes could be due to
the genetic factors or due to the induction of these
enzymes by environmental chemicals present in the
diet of these animals (39).
A number offoreign chemicals have been shown
to increase the hepatic drug metabolizing enzyme
activities. These chemicals are classified into two
major categories (40). The chemicals in Class I are
those which increase the metabolism ofalarge num-
ber ofdrug substrates accompanied by the increase
incytochrome P-450, while the chemicals in Class II
are more specific and induce the enzymic
metabolismofafewdrug substratesaccompaniedby
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Route Enzyme activity, % of control
of
Species administration AN hydroxylase AHH 7-EC deethylase
Mouse Oral NDa 516b 135
IP ND 96 25b
Rat Oral ND 879b 738b
IP ND 1615b 123lb
Guinea pig Oral 91 103 67
IP 9 240b 58b
Rabbit Oral 97 117 94
IP 68 83 96
aNot detected.
bSignificantly different from controls, p < 0.05.
the increase and shift of reduced cytochrome
P450-CO absorption spectra from 450 nm to 448 nm.
The Class I is exemplified by phenobarbital, a com-
monly used inducer of drug metabolizing enzymes.
The Class II of these chemicals is exemplified by
3-MC, one of the carcinogenic polycyclic hydro-
carbons. There is also another class of chemicals
which induces both cytochrome P450 and P-448-
mediated reactions of drug substrates and is rep-
resented by Arochlor 1254 and TCDD.
The effect of phenobarbital (Table 4) and 3-MC
(Table 5) on some of the xenobiotic metabolizing
enzymes in intestine of various species was studied
in our laboratory. The effect of these inducers on
cytochrome P-450 content is given in Table 6. The
results from this study showed that rabbit intestinal
xenobiotic metabolizing enzymes and cytochrome
P450 are not induced by either ofthe inducers used,
while the induction of xenobiotic metabolizing en-
zymes in other species depended on the type ofdrug
substrate and route of administration selected. The
lack of induction of xenobiotic metabolizing en-
zymes in rabbit small intestine could be due to the
maximum induced status ofthese enzymes in intes-
tinecaused bythe chemical contaminantinthe rabbit
feed. To test this hypothesis, rabbits were fed
semipurified diet for6-7 weeks and then treated with
phenobarbital or 3-MC for 3 days. Table 7 shows the
Table 6. Effect of phenobarbital and 3-methykcholanthrene on in-
testinal cytochrome P450.
Cytochrome P-450 content,
Route % of control
of
Species administration Pb 3-MC
Mouse Oral 221a 60
IP 139 41a
Rat Oral 73 104
IP 78 213a
Guinea pig Oral 107 iO9a
IP 104 100
Rabbit Oral 91 110
IP 98 63
aSignificantly different from controls, p < 0.05.
results ofthat study. The 3-MC orphenobarbital did
notinduce any ofthe enzymes studied indicating the
inability of rabbit enzyme system to respond to
chemical treatment. The resistance to induction of
rabbit intestinal enzymes by foreign chemicals
seems to be due to genetic factors rather than di-
etary.
Conclusions
Passive diffusion is the major process through
which intestinal transport ofxenobiotic takes place.
Table 7. Effect of purified diet and inducers on intestinal drug-metabolizing enzymes in rabbit.
Enzyme activity, % of controlsa
Ethylmorphine Aniline Arylhydrocarbon 7-Ethoxycoumarin
Treatment demethylase hydroxylase hydroxylase deethylase
Purified diet
plus PB (IP) 101 82 107 145
Purified diet
plus 3-MC (IP) 59 101 68
aControls were fed purified diet and injected with physiological saline (for Pb) or corn oil alone (for 3-MC).
lyp"-Ml-mber 1979 67The overall absorption of environmental chemicals
isoflesser magnitude through the lymphatic system
but is of greater toxicologic significance since the
chemicals are distributed throughout the body
without biotransformation by liver. The rate of ab-
sorption ofxenobiotics is determined by a numberof
factors.
The intestinal xenobiotic metabolizing enzymes in
their biochemical characteristics are similar to that
of liver. Though the rate of intestinal xenobiotic
metabolizingenzymes is 15 to50%ofthose observed
inliver, the surface areaofthe small intestine andthe
duration of a foreign chemical's residence in the
small intestine may be the determining factors in the
contribution of the small intestine to the overall
metabolism of xenobiotics in animals. A number of
factors, such as age, sex, hormones, nutrition, diur-
nalvariation, the content ofintestinal microfloracan
influence the rate of intestinal metabolism of
xenobiotics. The administration offoreign chemical
can stimulate the in vitro metabolism of some drug
substrates in various species studied in our labora-
tory. The exception was rabbit intestinal xenobiotic
metabolizing enzymes which were not induced by
phenobarbital or 3-MC pretreatment.
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